HEADER PROTEIN BINDING 15-NOV-19 6LBX TITLE CRYSTAL STRUCTURE OF HER2 DOMAIN IV AND RB-H2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPEBODY (RB-H2); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: DOMAIN IV; COMPND 9 SYNONYM: METASTATIC LYMPH NODE GENE 19 PROTEIN,MLN 19,PROTO-ONCOGENE COMPND 10 NEU,PROTO-ONCOGENE C-ERBB-2,TYROSINE KINASE-TYPE CELL SURFACE COMPND 11 RECEPTOR HER2,P185ERBB2; COMPND 12 EC: 2.7.10.1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CYCLOSTOMATA; SOURCE 3 ORGANISM_TAXID: 1476529; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: ERBB2, HER2, MLN19, NEU, NGL; SOURCE 11 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR H.S.CHO,J.S.CHA REVDAT 3 22-NOV-23 6LBX 1 REMARK REVDAT 2 24-MAR-21 6LBX 1 JRNL REVDAT 1 18-NOV-20 6LBX 0 JRNL AUTH T.Y.KIM,J.S.CHA,H.KIM,Y.CHOI,H.S.CHO,H.S.KIM JRNL TITL COMPUTATIONALLY-GUIDED DESIGN AND AFFINITY IMPROVEMENT OF A JRNL TITL 2 PROTEIN BINDER TARGETING A SPECIFIC SITE ON HER2 JRNL REF COMPUT STRUCT BIOTECHNOL J V. 19 1325 2021 JRNL REFN ESSN 2001-0370 JRNL DOI 10.1016/J.CSBJ.2021.02.013 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 25452 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.840 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.8900 - 4.8800 0.99 1840 156 0.1761 0.2089 REMARK 3 2 4.8800 - 3.8800 0.99 1751 149 0.1520 0.1843 REMARK 3 3 3.8800 - 3.3900 0.99 1708 146 0.1696 0.1895 REMARK 3 4 3.3900 - 3.0800 0.99 1705 145 0.1958 0.2405 REMARK 3 5 3.0800 - 2.8600 0.99 1694 144 0.2005 0.2300 REMARK 3 6 2.8600 - 2.6900 0.99 1676 142 0.2004 0.2512 REMARK 3 7 2.6900 - 2.5500 0.98 1664 142 0.1990 0.2830 REMARK 3 8 2.5500 - 2.4400 0.98 1669 141 0.2055 0.2548 REMARK 3 9 2.4400 - 2.3500 1.00 1652 141 0.2172 0.2760 REMARK 3 10 2.3500 - 2.2700 0.97 1653 141 0.2038 0.2634 REMARK 3 11 2.2700 - 2.2000 0.97 1637 139 0.2115 0.2382 REMARK 3 12 2.2000 - 2.1300 0.99 1644 140 0.2236 0.2659 REMARK 3 13 2.1300 - 2.0800 0.96 1638 138 0.2698 0.2771 REMARK 3 14 2.0800 - 2.0300 0.97 1594 136 0.3059 0.3212 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.226 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.876 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2694 REMARK 3 ANGLE : 1.080 3664 REMARK 3 CHIRALITY : 0.060 427 REMARK 3 PLANARITY : 0.006 474 REMARK 3 DIHEDRAL : 22.294 363 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LBX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1300014532. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25457 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 44.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.03120 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37770 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5B4P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM CITRATE/CITRIC ACID (PH REMARK 280 5.5), 20% PEG 3000, VAPOR DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.32950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.20300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.03550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.20300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.32950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.03550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 267 REMARK 465 LEU A 268 REMARK 465 GLU A 269 REMARK 465 HIS A 270 REMARK 465 HIS A 271 REMARK 465 HIS A 272 REMARK 465 HIS A 273 REMARK 465 HIS A 274 REMARK 465 HIS A 275 REMARK 465 SER B 602 REMARK 465 GLY B 603 REMARK 465 VAL B 604 REMARK 465 LYS B 605 REMARK 465 PRO B 606 REMARK 465 ASP B 607 REMARK 465 LEU B 608 REMARK 465 SER B 609 REMARK 465 TYR B 610 REMARK 465 MET B 611 REMARK 465 PRO B 612 REMARK 465 ILE B 613 REMARK 465 TRP B 614 REMARK 465 LYS B 615 REMARK 465 PHE B 616 REMARK 465 PRO B 617 REMARK 465 ASP B 618 REMARK 465 GLU B 619 REMARK 465 GLU B 620 REMARK 465 GLY B 621 REMARK 465 ALA B 622 REMARK 465 CYS B 623 REMARK 465 GLN B 624 REMARK 465 PRO B 625 REMARK 465 CYS B 626 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 576 CB CYS B 576 SG -0.164 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 49 55.35 -141.90 REMARK 500 LEU A 63 70.95 -111.03 REMARK 500 ASN A 74 -155.12 -109.38 REMARK 500 ASN A 96 -150.50 -114.08 REMARK 500 ASN A 120 -152.24 -121.86 REMARK 500 ASN A 144 -159.37 -131.27 REMARK 500 LEU A 157 58.63 -92.58 REMARK 500 ASN A 168 -157.64 -114.02 REMARK 500 LEU A 181 58.63 -90.11 REMARK 500 ASN A 192 -168.09 -129.48 REMARK 500 CYS A 220 32.14 -94.01 REMARK 500 ALA A 247 73.23 -158.26 REMARK 500 GLN B 533 -104.32 -117.01 REMARK 500 HIS B 589 -92.51 -128.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 6LBX A 1 275 PDB 6LBX 6LBX 1 275 DBREF 6LBX B 531 626 UNP P04626 ERBB2_HUMAN 531 626 SEQADV 6LBX GLN B 530 UNP P04626 EXPRESSION TAG SEQRES 1 A 275 MET GLU THR ILE THR VAL SER THR PRO ILE LYS GLN ILE SEQRES 2 A 275 PHE PRO ASP ASP ALA PHE ALA GLU THR ILE LYS ALA ASN SEQRES 3 A 275 LEU LYS LYS LYS SER VAL THR ASP ALA VAL THR GLN ASN SEQRES 4 A 275 GLU LEU ASN SER ILE ASP LEU ILE SER ALA PRO HIS SER SEQRES 5 A 275 ASP ILE LYS SER VAL GLN GLY ILE GLN TYR LEU PRO ASN SEQRES 6 A 275 VAL ARG LEU LEU TYR LEU GLY GLY ASN LYS LEU HIS ASP SEQRES 7 A 275 ILE SER ALA LEU LYS GLU LEU THR ASN LEU THR THR LEU SEQRES 8 A 275 ILE LEU SER GLY ASN GLN LEU GLN SER LEU PRO ASN GLY SEQRES 9 A 275 VAL PHE ASP LYS LEU THR ASN LEU LYS VAL LEU TRP LEU SEQRES 10 A 275 SER VAL ASN GLN LEU GLN SER LEU PRO ASP GLY VAL PHE SEQRES 11 A 275 ASP LYS LEU THR ASN LEU THR SER LEU ARG LEU HIS ARG SEQRES 12 A 275 ASN GLN LEU GLN SER LEU PRO LYS GLY VAL PHE ASP LYS SEQRES 13 A 275 LEU THR ASN LEU THR VAL LEU ARG LEU SER GLU ASN GLN SEQRES 14 A 275 LEU GLN SER LEU PRO GLU GLY VAL PHE ASP LYS LEU THR SEQRES 15 A 275 GLN LEU LYS VAL LEU TRP LEU GLY ARG ASN GLN LEU LYS SEQRES 16 A 275 SER VAL PRO ASP GLY VAL PHE ASP ARG LEU THR SER LEU SEQRES 17 A 275 GLN TYR ILE TRP LEU HIS ASP ASN PRO TRP ASP CYS THR SEQRES 18 A 275 CYS PRO GLY ILE ARG TYR LEU SER GLU TRP ILE ASN LYS SEQRES 19 A 275 HIS SER GLY VAL VAL ARG ASN SER ALA GLY SER VAL ALA SEQRES 20 A 275 PRO ASP SER ALA LYS CYS SER GLY SER GLY LYS PRO VAL SEQRES 21 A 275 ARG SER ILE ILE CYS PRO THR LEU GLU HIS HIS HIS HIS SEQRES 22 A 275 HIS HIS SEQRES 1 B 97 GLN CYS SER GLN PHE LEU ARG GLY GLN GLU CYS VAL GLU SEQRES 2 B 97 GLU CYS ARG VAL LEU GLN GLY LEU PRO ARG GLU TYR VAL SEQRES 3 B 97 ASN ALA ARG HIS CYS LEU PRO CYS HIS PRO GLU CYS GLN SEQRES 4 B 97 PRO GLN ASN GLY SER VAL THR CYS PHE GLY PRO GLU ALA SEQRES 5 B 97 ASP GLN CYS VAL ALA CYS ALA HIS TYR LYS ASP PRO PRO SEQRES 6 B 97 PHE CYS VAL ALA ARG CYS PRO SER GLY VAL LYS PRO ASP SEQRES 7 B 97 LEU SER TYR MET PRO ILE TRP LYS PHE PRO ASP GLU GLU SEQRES 8 B 97 GLY ALA CYS GLN PRO CYS HET NAG B 701 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 HOH *148(H2 O) HELIX 1 AA1 ILE A 10 PHE A 14 1 5 HELIX 2 AA2 ASP A 16 LEU A 27 1 12 HELIX 3 AA3 THR A 37 SER A 43 1 7 HELIX 4 AA4 GLY A 59 LEU A 63 5 5 HELIX 5 AA5 ILE A 79 LYS A 83 5 5 HELIX 6 AA6 ILE A 225 HIS A 235 1 11 HELIX 7 AA7 ALA A 247 ALA A 251 5 5 HELIX 8 AA8 PRO A 259 ILE A 263 5 5 SHEET 1 AA1 2 THR A 8 PRO A 9 0 SHEET 2 AA1 2 ALA A 35 VAL A 36 -1 O VAL A 36 N THR A 8 SHEET 1 AA2 8 LEU A 46 SER A 48 0 SHEET 2 AA2 8 LEU A 68 TYR A 70 1 O TYR A 70 N ILE A 47 SHEET 3 AA2 8 THR A 90 ILE A 92 1 O ILE A 92 N LEU A 69 SHEET 4 AA2 8 VAL A 114 TRP A 116 1 O VAL A 114 N LEU A 91 SHEET 5 AA2 8 SER A 138 ARG A 140 1 O SER A 138 N LEU A 115 SHEET 6 AA2 8 VAL A 162 ARG A 164 1 O VAL A 162 N LEU A 139 SHEET 7 AA2 8 VAL A 186 TRP A 188 1 O VAL A 186 N LEU A 163 SHEET 8 AA2 8 TYR A 210 TRP A 212 1 O TYR A 210 N LEU A 187 SHEET 1 AA3 2 PHE B 534 ARG B 536 0 SHEET 2 AA3 2 GLU B 539 VAL B 541 -1 O VAL B 541 N PHE B 534 SHEET 1 AA4 2 GLU B 553 ASN B 556 0 SHEET 2 AA4 2 HIS B 559 PRO B 562 -1 O LEU B 561 N TYR B 554 SHEET 1 AA5 2 TYR B 590 ASP B 592 0 SHEET 2 AA5 2 PHE B 595 VAL B 597 -1 O PHE B 595 N ASP B 592 SSBOND 1 CYS A 220 CYS A 253 1555 1555 2.00 SSBOND 2 CYS A 222 CYS A 265 1555 1555 2.04 SSBOND 3 CYS B 531 CYS B 540 1555 1555 2.05 SSBOND 4 CYS B 544 CYS B 560 1555 1555 2.04 SSBOND 5 CYS B 563 CYS B 576 1555 1555 2.04 SSBOND 6 CYS B 567 CYS B 584 1555 1555 2.13 SSBOND 7 CYS B 587 CYS B 596 1555 1555 2.05 LINK ND2 ASN B 571 C1 NAG B 701 1555 1555 1.45 CISPEP 1 CYS A 222 PRO A 223 0 5.53 CISPEP 2 LEU B 550 PRO B 551 0 -4.85 CISPEP 3 PRO B 593 PRO B 594 0 7.98 CRYST1 44.659 80.071 108.406 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022392 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012489 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009225 0.00000